Independent US Healthcare Provider Directory & Public Medical Database Patient Guides
T-MedInfo US Healthcare Directory

Dr. Igor Chaplik , DO

Dermatology • Ft Lauderdale, FL

Active NPI 1952410789 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

4331 N Federal Hwy Ste 400
Ft Lauderdale, FL 33308

Call 9547720416 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

4331 N Federal Hwy Ste 400

Ft Lauderdale, FL 33308

Telephone 9547720416
Fax 9547725716
Before You Book

Paying without insurance? Prepare a cost-estimate request

Ask about interpreters and office accessibility

Organization at the Same NPPES Address or Phone
Aesthetix Skin And Surgery Center Facility NPI 1588162655

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Aesthetix Skin And Surgery Center. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Graduation Year

2000

What Public CMS Data Show

These CMS figures cover limited populations and published records; they are not quality ratings or medical advice.

Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.

Medicare patients

602 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

It gives a sense of how many people with Medicare this clinician treated that year.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $494,531 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $367,482 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

The gap between the allowed amount and this number is roughly what patients and their other insurance paid.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,517 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$213,044 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

It shows the total spending on drugs this clinician prescribed, not what any one patient paid.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $2,235.40 across 102 records.

By nature of payment

  • Food and Beverage: $2,235.40 across 102 records.

Reporting-company totals (3 largest of 20)

  • ABBVIE INC.: $453.38 across 19 records.
  • Janssen Pharmaceuticals, Inc: $398.91 across 26 records.
  • UCB, Inc.: $185.36 across 6 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

26 years (graduated 2000)

CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.

It tells you roughly how long ago the clinician finished school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Chaplik has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Chaplik as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

Medicare pays for these items and services only when they are ordered by an eligible clinician.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Ft Lauderdale and Florida

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 70% of clinicians listed under Dermatology in Florida (2024, 839 clinicians with data). Median for this group: 3,320. Middle half: 1,291 to 7,083.

Too few clinicians listed under Dermatology in Ft Lauderdale have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 70% of clinicians listed under Dermatology in Florida (2024, 839 clinicians with data). Median for this group: $234,319. Middle half: $93,185 to $522,086.

Too few clinicians listed under Dermatology in Ft Lauderdale have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 70% of clinicians listed under Dermatology in Florida (2024, 839 clinicians with data). Median for this group: $170,010. Middle half: $65,604 to $385,623.

Too few clinicians listed under Dermatology in Ft Lauderdale have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 80% of clinicians listed under Dermatology in Florida (2024, 913 clinicians with data). Median for this group: 606. Middle half: 256 to 1,130.

Too few clinicians listed under Dermatology in Ft Lauderdale have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 80% of clinicians listed under Dermatology in Florida (2024, 913 clinicians with data). Median for this group: $30,116. Middle half: $5,879 to $163,505.

Too few clinicians listed under Dermatology in Ft Lauderdale have Medicare Part D data for 2024 to compare.

6 active clinicians are listed under Dermatology with a practice address in Ft Lauderdale, FL (1,225 in Florida).

Addresses are self-reported to NPPES and may be out of date.

CMS data by year

Changes may reflect reporting, coverage or privacy limits, not changes in care quality.

  • Medicare Part B services

    Medicare Part B services increased 25% from 5,555 in 2020 to 6,935 in 2024.

    • 2020: 5,555
    • 2021: 5,850
    • 2022: 6,553
    • 2023: 7,156
    • 2024: 6,935

  • Medicare-allowed amount

    Medicare-allowed amount increased 44% from $343,019 in 2020 to $494,531 in 2024.

    • 2020: $343,019
    • 2021: $402,237
    • 2022: $433,568
    • 2023: $502,890
    • 2024: $494,531

  • Paid by Medicare

    Paid by Medicare increased 45% from $252,609 in 2020 to $367,482 in 2024.

    • 2020: $252,609
    • 2021: $304,087
    • 2022: $322,044
    • 2023: $378,369
    • 2024: $367,482

  • Medicare Part D prescriptions

    Medicare Part D prescriptions increased 49% from 933 in 2020 to 1,387 in 2024.

    • 2020: 933
    • 2021: 1,102
    • 2022: 1,174
    • 2023: 1,220
    • 2024: 1,387

  • 30-day fills

    30-day fills increased 53% from 989 in 2020 to 1,517 in 2024.

    • 2020: 989
    • 2021: 1,180
    • 2022: 1,263
    • 2023: 1,342
    • 2024: 1,517

  • Part D drug cost

    Part D drug cost increased 167% from $79,934 in 2020 to $213,044 in 2024.

    • 2020: $79,934
    • 2021: $353,305
    • 2022: $320,119
    • 2023: $292,566
    • 2024: $213,044

  • Industry payments (Open Payments)

    Industry payments (Open Payments) increased 43% from $1,558.71 in 2021 to $2,235.40 in 2025.

    • 2021: $1,558.71
    • 2022: $1,691.26
    • 2023: $1,626.98
    • 2024: $2,116.61
    • 2025: $2,235.40

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 102 records totaling $2,235.40.

Manufacturer Payment Nature Product Type Amount ($)
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
 TREMFYA General $133.35
ABBVIE INC.
Food and Beverage
In-kind items and services
 SKYRIZI General $129.54
REVANCE THERAPEUTICS, INC.
Food and Beverage
In-kind items and services
 DAXXIFY General $85.21
REVANCE THERAPEUTICS, INC.
Food and Beverage
In-kind items and services
 DAXXIFY General $46.76
ABBVIE INC.
Food and Beverage
In-kind items and services
 RINVOQ General $39.19
UCB, Inc.
Food and Beverage
In-kind items and services
 Bimzelx General $38.60
Organon LLC
Food and Beverage
In-kind items and services
 — General $36.17
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
 DUPIXENT General $34.61
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
 DUPIXENT General $34.17
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
 DUPIXENT General $32.69
UCB, Inc.
Food and Beverage
In-kind items and services
 Bimzelx General $32.31
REVANCE THERAPEUTICS, INC.
Food and Beverage
In-kind items and services
 DAXXIFY General $32.21
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
 DUPIXENT General $31.57
UCB, Inc.
Food and Beverage
In-kind items and services
 Bimzelx General $31.41
Organon LLC
Food and Beverage
In-kind items and services
 — General $31.17
Amgen Inc.
Food and Beverage
In-kind items and services
 OTEZLA General $30.45
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 COSENTYX General $30.39
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 COSENTYX General $30.02
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
 SPEVIGO General $28.77
UCB, Inc.
Food and Beverage
In-kind items and services
 Bimzelx General $28.19
UCB, Inc.
Food and Beverage
In-kind items and services
 Bimzelx General $28.19
Incyte Corporation
Food and Beverage
Cash or cash equivalent
 OPZELURA General $27.92
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
 SPEVIGO General $27.61
Incyte Corporation
Food and Beverage
Cash or cash equivalent
 OPZELURA General $27.39
ABBVIE INC.
Food and Beverage
In-kind items and services
 SKYRIZI General $27.35

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

A reported payment does not necessarily indicate wrongdoing; clinicians can dispute a record with CMS.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
3,068 316 $9.93 $6.49
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
1,046 468 $139.38 $91.28
17000 Destruction of precancer skin growth, 1 growth
705 368 $103.61 $52.96
11102 Biopsy of related skin growth, first growth
453 301 $156.63 $97.31
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
188 124 $196.95 $129.56
11103 Biopsy of related skin growth, each additional growth
156 98 $76.54 $49.95
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
129 104 $86.71 $56.64
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
127 127 $172.31 $112.22
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
116 92 $1039.70 $632.65
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
102 28 $1.44 $0.95
J9190 Injection, fluorouracil, 500 mg
93 34 $4.41 $2.89
96405 Administration of chemotherapy into growth, 1-7
87 28 $124.41 $76.78
17110 Destruction of skin growth, 1-14 growths
63 48 $173.01 $109.47
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
63 44 $635.95 $413.35
17004 Destruction of precancer skin growth, 15 or more growths
50 41 $255.56 $168.19
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
50 39 $273.65 $160.12
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
47 41 $651.86 $277.52
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
45 39 $723.20 $242.58
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
44 38 $592.46 $388.65
96574 Application of light with debridement to destroy precancer skin growth
42 37 $415.01 $272.70
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
39 28 $976.98 $641.36
69100 Biopsy of ear
29 24 $146.16 $77.84
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
26 26 $259.18 $170.29
11104 Punch biopsy, first skin growth
25 24 $190.43 $122.72
11900 Injection into skin growth, 1-7 growths
24 22 $87.85 $43.36

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 306 9,059 $2,331.61 210
Clobetasol Propionate Clobetasol Propionate 281 8,363 $9,702.80 176
Doxycycline Hyclate Doxycycline Hyclate 174 1,916 $1,466.32 142
Ciclopirox Ciclopirox Olamine 99 3,138 $2,129.08 72
Fluorouracil Fluorouracil 74 2,124 $4,717.45 61
Ketoconazole Ketoconazole 62 1,810 $786.25 33
Valacyclovir Valacyclovir Hcl 57 1,366 $1,437.50 32
Clindamycin Phosphate Clindamycin Phosphate 53 1,635 $1,598.09 25
Hydrocortisone Hydrocortisone 35 881 $120.80 26
Fluconazole Fluconazole 33 1,677 $215.25 22
Mupirocin Mupirocin 30 610 $223.51 23
Tretinoin Tretinoin 25 910 $2,102.71 12
Hydroxyzine Hcl Hydroxyzine Hcl 21 750 $129.74 14
Ciclopirox Ciclopirox 19 533 $332.67 11
Gentamicin Sulfate Gentamicin Sulfate 19 449 $663.72 17
Metronidazole Metronidazole 18 560 $925.34 12
Ammonium Lactate Ammonium Lactate 17 510 $254.14 11
Cosentyx Sensoready (2 Pens) Secukinumab 16 448 $121,600.44 —
Otezla Apremilast 13 390 $60,492.76 —
Levofloxacin Levofloxacin 12 82 $22.09 —
Ivermectin Ivermectin 12 305 $1,609.87 —
Permethrin Permethrin 11 85 $181.56 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES FL OS9145

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Florida Department of Health Medical Quality Assurance.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20041202000221

Enrollment State Jurisdiction

FL

PECOS Control ID

3678539640

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Aesthetix Skin And Surgery Center

4331 N Federal Hwy, Ft Lauderdale, FL 333085252

Phone: 9547720416

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
Nicole Gentile , PA-C

Physician Assistant

NPI 1073816005

Physician Assistant (Certified)

NPI 1427167261

Doctor of Osteopathic Medicine (D.O.)

NPI 1407143670

Doctor of Osteopathic Medicine (D.O.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

9 Historical Events
📍
Updated Practice Location August 27, 2018

Registered at 4331 N FEDERAL HWY STE 400, FT LAUDERDALE, FL 33308 (Tel: 9547720416)

📍
Updated Practice Location May 17, 2018

Registered at 4331 N FEDERAL HWY STE 400, OAKLAND PARK, FL 33308 (Tel: 9547720416)

📍
Updated Business Mailing Address May 17, 2018

Registered at 151 SOUTHHALL LN STE 300, MAITLAND, FL 327517172 (Tel: 4078752080)

✅
NPI Profile Active July 08, 2007

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) July 08, 2007

Registered at 5721 NE 27TH AVE, FORT LAUDERDALE, FL 333082703 (Tel: 9547720416)

📍
Business Mailing Address (Initial Record) July 08, 2007

Registered at 2600 LAKE LUCIEN DR STE 180, MAITLAND, FL 327517235 (Tel: 4078752080)

👤
Provider Name / Credentials (Initial Record) July 08, 2007

Recorded as IGOR CHAPLIK, DO

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) July 08, 2007

Dermatology (license number reported to NPPES: FL OS9145)

🟢
Initial NPI Registration & Enumeration August 29, 2006

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1952410789
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: August 29, 2006
Last Update: August 27, 2018
Sole Proprietor: No
Update or Correct Profile

Other Dermatology Specialists in Ft Lauderdale

Healthcare providers in Ft Lauderdale

Mailing Address

151 Southhall Ln Ste 300

Maitland, FL 327517172

Phone: 4078752080

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.